eflornithine + sulindac

eflornithine + sulindac
Trade Name not avaiable
Orphan Indication 1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol;1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole
EU Market Approval EU
EU Designation Date 2018-01-09 00:00:00
Sponsor Cancer Prevention Pharmaceutical, Inc. 1760 East River Road, Suite 250 Tucson, Arizona, 85718